0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-11Z3168
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Market Insights and Forecast to 2028
BUY CHAPTERS

Global Erectile Dysfunction Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-11Z3168
Report
October 2022
Pages:119
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Erectile Dysfunction market is projected to reach US$ 8108.8 million by 2028 from an estimated US$ 5391.1 million in 2022, at a CAGR of 7.0% during 2023 and 2028.

Eli Lilly is one of the most important global key manufacturers of erectile dysfunction, holds a share of about 10%, other key players include Teva Pharma and Pfizer, etc. North America is the largest market, occupied for over 40 percent, followed by Europe. In terms of type, tadalafil type is the largest segment, with a share of over 50%, and in terms of sales channels, the hospital pharmacies segment holds a share of over 30 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction.
The Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (Million Pill) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Product Type Insights
Global markets are presented by Erectile Dysfunction type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Erectile Dysfunction are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Erectile Dysfunction Segment by Type

Sildenafil
Tadalafil
Others
Application Insights
This report has provided the market size (sales and revenue data) by sales channels, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Erectile Dysfunction market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Erectile Dysfunction market.
Erectile Dysfunction Segment by Sales Channels
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Erectile Dysfunction market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Erectile Dysfunction industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Erectile Dysfunction Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Sales Channels
1.3.1 Global Erectile Dysfunction Market Size Growth Rate by Sales Channels (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Market Size Estimates and Forecasts
2.1.1 Global Erectile Dysfunction Revenue 2017-2028
2.1.2 Global Erectile Dysfunction Sales 2017-2028
2.2 Erectile Dysfunction Market Size by Region: 2022 Versus 2028
2.3 Erectile Dysfunction Sales by Region (2017-2028)
2.3.1 Global Erectile Dysfunction Sales by Region: 2017-2022
2.3.2 Global Erectile Dysfunction Sales Forecast by Region (2023-2028)
2.3.3 Global Erectile Dysfunction Sales Market Share by Region (2017-2028)
2.4 Erectile Dysfunction Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Erectile Dysfunction Revenue by Region: 2017-2022
2.4.2 Global Erectile Dysfunction Revenue Forecast by Region (2023-2028)
2.4.3 Global Erectile Dysfunction Revenue Market Share by Region (2017-2028)
3 Global Erectile Dysfunction by Manufacturers
3.1 Global Top Erectile Dysfunction Manufacturers by Sales
3.1.1 Global Erectile Dysfunction Sales by Manufacturer (2017-2022)
3.1.2 Global Erectile Dysfunction Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Erectile Dysfunction Manufacturers by Revenue
3.2.1 Global Erectile Dysfunction Revenue by Manufacturer (2017-2022)
3.2.2 Global Erectile Dysfunction Revenue Share by Manufacturer (2017-2022)
3.3 Global Erectile Dysfunction Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Erectile Dysfunction Manufacturers Covered: Ranking by Revenue
3.4.2 Global Erectile Dysfunction Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Erectile Dysfunction Manufacturing Base Distribution, Product Type
3.5.1 Erectile Dysfunction Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Erectile Dysfunction Product Type
3.5.3 Date of International Manufacturers Enter into Erectile Dysfunction Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Eli Lilly
4.1.1 Eli Lilly Corporation Information
4.1.2 Eli Lilly Description, Business Overview
4.1.3 Eli Lilly Erectile Dysfunction Products Offered
4.1.4 Eli Lilly Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Eli Lilly Erectile Dysfunction Sales by Product in 2021
4.1.6 Eli Lilly Erectile Dysfunction Sales by Sales Channels in 2021
4.1.7 Eli Lilly Erectile Dysfunction Sales by Geographic Area in 2021
4.1.8 Eli Lilly Recent Developments
4.2 Pfizer
4.2.1 Pfizer Corporation Information
4.2.2 Pfizer Description, Business Overview
4.2.3 Pfizer Erectile Dysfunction Products Offered
4.2.4 Pfizer Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Pfizer Erectile Dysfunction Sales by Product in 2021
4.2.6 Pfizer Erectile Dysfunction Sales by Sales Channels in 2021
4.2.7 Pfizer Erectile Dysfunction Sales by Geographic Area in 2021
4.2.8 Pfizer Recent Developments
4.3 Bayer
4.3.1 Bayer Corporation Information
4.3.2 Bayer Description, Business Overview
4.3.3 Bayer Erectile Dysfunction Products Offered
4.3.4 Bayer Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bayer Erectile Dysfunction Sales by Product in 2021
4.3.6 Bayer Erectile Dysfunction Sales by Sales Channels in 2021
4.3.7 Bayer Erectile Dysfunction Sales by Geographic Area in 2021
4.3.8 Bayer Recent Developments
4.4 BaiYunShan General Factory
4.4.1 BaiYunShan General Factory Corporation Information
4.4.2 BaiYunShan General Factory Description, Business Overview
4.4.3 BaiYunShan General Factory Erectile Dysfunction Products Offered
4.4.4 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.4.5 BaiYunShan General Factory Erectile Dysfunction Sales by Product in 2021
4.4.6 BaiYunShan General Factory Erectile Dysfunction Sales by Sales Channels in 2021
4.4.7 BaiYunShan General Factory Erectile Dysfunction Sales by Geographic Area in 2021
4.4.8 BaiYunShan General Factory Recent Developments
4.5 S.K. Chemicals
4.5.1 S.K. Chemicals Corporation Information
4.5.2 S.K. Chemicals Description, Business Overview
4.5.3 S.K. Chemicals Erectile Dysfunction Products Offered
4.5.4 S.K. Chemicals Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.5.5 S.K. Chemicals Erectile Dysfunction Sales by Product in 2021
4.5.6 S.K. Chemicals Erectile Dysfunction Sales by Sales Channels in 2021
4.5.7 S.K. Chemicals Erectile Dysfunction Sales by Geographic Area in 2021
4.5.8 S.K. Chemicals Recent Developments
4.6 Teva Pharma
4.6.1 Teva Pharma Corporation Information
4.6.2 Teva Pharma Description, Business Overview
4.6.3 Teva Pharma Erectile Dysfunction Products Offered
4.6.4 Teva Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharma Erectile Dysfunction Sales by Product in 2021
4.6.6 Teva Pharma Erectile Dysfunction Sales by Sales Channels in 2021
4.6.7 Teva Pharma Erectile Dysfunction Sales by Geographic Area in 2021
4.6.8 Teva Pharma Recent Development
4.7 Dong-A ST
4.7.1 Dong-A ST Corporation Information
4.7.2 Dong-A ST Description, Business Overview
4.7.3 Dong-A ST Erectile Dysfunction Products Offered
4.7.4 Dong-A ST Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Dong-A ST Erectile Dysfunction Sales by Product in 2021
4.7.6 Dong-A ST Erectile Dysfunction Sales by Sales Channels in 2021
4.7.7 Dong-A ST Erectile Dysfunction Sales by Geographic Area in 2021
4.7.8 Dong-A ST Recent Development
4.8 Petros Pharmaceuticals
4.8.1 Petros Pharmaceuticals Corporation Information
4.8.2 Petros Pharmaceuticals Description, Business Overview
4.8.3 Petros Pharmaceuticals Erectile Dysfunction Products Offered
4.8.4 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Petros Pharmaceuticals Erectile Dysfunction Sales by Product in 2021
4.8.6 Petros Pharmaceuticals Erectile Dysfunction Sales by Sales Channels in 2021
4.8.7 Petros Pharmaceuticals Erectile Dysfunction Sales by Geographic Area in 2021
4.8.8 Petros Pharmaceuticals Recent Development
4.9 Seoul Pharma
4.9.1 Seoul Pharma Corporation Information
4.9.2 Seoul Pharma Description, Business Overview
4.9.3 Seoul Pharma Erectile Dysfunction Products Offered
4.9.4 Seoul Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Seoul Pharma Erectile Dysfunction Sales by Product in 2021
4.9.6 Seoul Pharma Erectile Dysfunction Sales by Sales Channels in 2021
4.9.7 Seoul Pharma Erectile Dysfunction Sales by Geographic Area in 2021
4.9.8 Seoul Pharma Recent Development
4.10 Yabang Pharmacy
4.10.1 Yabang Pharmacy Corporation Information
4.10.2 Yabang Pharmacy Description, Business Overview
4.10.3 Yabang Pharmacy Erectile Dysfunction Products Offered
4.10.4 Yabang Pharmacy Erectile Dysfunction Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Yabang Pharmacy Erectile Dysfunction Sales by Product in 2021
4.10.6 Yabang Pharmacy Erectile Dysfunction Sales by Sales Channels in 2021
4.10.7 Yabang Pharmacy Erectile Dysfunction Sales by Geographic Area in 2021
4.10.8 Yabang Pharmacy Recent Development
5 Breakdown Data by Type
5.1 Global Erectile Dysfunction Sales by Type (2017-2028)
5.1.1 Global Erectile Dysfunction Sales by Type (2017-2022)
5.1.2 Global Erectile Dysfunction Sales Forecast by Type (2023-2028)
5.1.3 Global Erectile Dysfunction Sales Market Share by Type (2017-2028)
5.2 Global Erectile Dysfunction Revenue Forecast by Type (2017-2028)
5.2.1 Global Erectile Dysfunction Revenue by Type (2017-2022)
5.2.2 Global Erectile Dysfunction Revenue Forecast by Type (2023-2028)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2017-2028)
5.3 Erectile Dysfunction Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Sales Channels
6.1 Global Erectile Dysfunction Sales by Sales Channels (2017-2028)
6.1.1 Global Erectile Dysfunction Sales by Sales Channels (2017-2022)
6.1.2 Global Erectile Dysfunction Sales Forecast by Sales Channels (2023-2028)
6.1.3 Global Erectile Dysfunction Sales Market Share by Sales Channels (2017-2028)
6.2 Global Erectile Dysfunction Revenue Forecast by Sales Channels (2017-2028)
6.2.1 Global Erectile Dysfunction Revenue by Sales Channels (2017-2022)
6.2.2 Global Erectile Dysfunction Revenue Forecast by Sales Channels (2023-2028)
6.2.3 Global Erectile Dysfunction Revenue Market Share by Sales Channels (2017-2028)
6.3 Erectile Dysfunction Average Selling Price (ASP) by Sales Channels (2017-2028)
7 North America
7.1 North America Erectile Dysfunction Market Size YoY Growth 2017-2028
7.2 North America Erectile Dysfunction Market Facts & Figures by Country
7.2.1 North America Erectile Dysfunction Sales by Country (2017-2028)
7.2.2 North America Erectile Dysfunction Revenue by Country (2017-2028)
7.3 North America Erectile Dysfunction Sales by Type
7.4 North America Erectile Dysfunction Sales by Sales Channels
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Erectile Dysfunction Market Facts & Figures by Region
8.2.1 Asia-Pacific Erectile Dysfunction Sales by Region (2017-2028)
8.2.2 Asia-Pacific Erectile Dysfunction Revenue by Region (2017-2028)
8.3 Asia-Pacific Erectile Dysfunction Sales by Type
8.4 Asia-Pacific Erectile Dysfunction Sales by Sales Channels
9 Europe
9.1 Europe Erectile Dysfunction Market Size YoY Growth 2017-2028
9.2 Europe Erectile Dysfunction Market Facts & Figures by Country
9.2.1 Europe Erectile Dysfunction Sales by Country (2017-2028)
9.2.2 Europe Erectile Dysfunction Revenue by Country (2017-2028)
9.3 Europe Erectile Dysfunction Sales by Type
9.4 Europe Erectile Dysfunction Sales by Sales Channels
10 Latin America
10.1 Latin America Erectile Dysfunction Market Size YoY Growth 2017-2028
10.2 Latin America Erectile Dysfunction Market Facts & Figures by Country
10.2.1 Latin America Erectile Dysfunction Sales by Country (2017-2028)
10.2.2 Latin America Erectile Dysfunction Revenue by Country (2017-2028)
10.3 Latin America Erectile Dysfunction Sales by Type
10.4 Latin America Erectile Dysfunction Sales by Sales Channels
11 Middle East and Africa
11.1 Middle East and Africa Erectile Dysfunction Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Erectile Dysfunction Market Facts & Figures by Country
11.2.1 Middle East and Africa Erectile Dysfunction Sales by Country (2017-2028)
11.2.2 Middle East and Africa Erectile Dysfunction Revenue by Country (2017-2028)
11.3 Middle East and Africa Erectile Dysfunction Sales by Type
11.4 Middle East and Africa Erectile Dysfunction Sales by Sales Channels
12 Supply Chain and Sales Channel Analysis
12.1 Erectile Dysfunction Supply Chain Analysis
12.2 Erectile Dysfunction Key Raw Materials and Upstream Suppliers
12.3 Erectile Dysfunction Clients Analysis
12.4 Erectile Dysfunction Sales Channel and Sales Model Analysis
12.4.1 Erectile Dysfunction Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Erectile Dysfunction Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Erectile Dysfunction Distributors
13 Market Dynamics
13.1 Erectile Dysfunction Industry Trends
13.2 Erectile Dysfunction Market Drivers
13.3 Erectile Dysfunction Market Challenges
13.4 Erectile Dysfunction Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Erectile Dysfunction Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Sildenafil
    Table 3. Major Manufacturers of Tadalafil
    Table 4. Major Manufacturers of Others
    Table 5. Global Erectile Dysfunction Market Size Growth by Sales Channels (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Erectile Dysfunction Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 7. Global Erectile Dysfunction Sales by Region (2017-2022) & (Million Pill)
    Table 8. Global Erectile Dysfunction Sales Forecast by Region (2023-2028) & (Million Pill)
    Table 9. Global Erectile Dysfunction Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Erectile Dysfunction Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 11. Global Erectile Dysfunction Sales by Manufacturer (2017-2022) & (Million Pill)
    Table 12. Global Erectile Dysfunction Sales Share by Manufacturer (2017-2022)
    Table 13. Erectile Dysfunction Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 14. Erectile Dysfunction Revenue Share by Manufacturer (2017-2022)
    Table 15. Key Manufacturers Erectile Dysfunction Price (2017-2022) & (USD/Pill)
    Table 16. Ranking of Global Top Erectile Dysfunction Manufacturers by Revenue (US$ Million) in 2021
    Table 17. Global Erectile Dysfunction Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 18. Global Erectile Dysfunction by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erectile Dysfunction as of 2021)
    Table 19. Erectile Dysfunction Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Erectile Dysfunction Product Type
    Table 21. Date of International Manufacturers Enter into Erectile Dysfunction Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Eli Lilly Corporation Information
    Table 24. Eli Lilly Description and Business Overview
    Table 25. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 26. Eli Lilly Erectile Dysfunction Product
    Table 27. Eli Lilly Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 28. Eli Lilly Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 29. Eli Lilly Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 30. Eli Lilly Recent Development
    Table 31. Pfizer Corporation Information
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 34. Pfizer Erectile Dysfunction Product
    Table 35. Pfizer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 36. Pfizer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 37. Pfizer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 38. Pfizer Recent Development
    Table 39. Bayer Corporation Information
    Table 40. Bayer Description and Business Overview
    Table 41. Bayer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 42. Bayer Erectile Dysfunction Product
    Table 43. Bayer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 44. Bayer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 45. Bayer Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 46. Bayer Recent Development
    Table 47. BaiYunShan General Factory Corporation Information
    Table 48. BaiYunShan General Factory Description and Business Overview
    Table 49. BaiYunShan General Factory Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 50. BaiYunShan General Factory Erectile Dysfunction Product
    Table 51. BaiYunShan General Factory Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 52. BaiYunShan General Factory Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 53. BaiYunShan General Factory Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 54. BaiYunShan General Factory Recent Development
    Table 55. S.K. Chemicals Corporation Information
    Table 56. S.K. Chemicals Description and Business Overview
    Table 57. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 58. S.K. Chemicals Erectile Dysfunction Product
    Table 59. S.K. Chemicals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 60. S.K. Chemicals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 61. S.K. Chemicals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 62. S.K. Chemicals Recent Development
    Table 63. Teva Pharma Corporation Information
    Table 64. Teva Pharma Description and Business Overview
    Table 65. Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 66. Teva Pharma Erectile Dysfunction Product
    Table 67. Teva Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 68. Teva Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 69. Teva Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 70. Dong-A ST Corporation Information
    Table 71. Dong-A ST Description and Business Overview
    Table 72. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 73. Dong-A ST Erectile Dysfunction Product
    Table 74. Dong-A ST Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 75. Dong-A ST Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 76. Dong-A ST Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 77. Petros Pharmaceuticals Corporation Information
    Table 78. Petros Pharmaceuticals Description and Business Overview
    Table 79. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 80. Petros Pharmaceuticals Erectile Dysfunction Product
    Table 81. Petros Pharmaceuticals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 82. Petros Pharmaceuticals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 83. Petros Pharmaceuticals Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 84. Seoul Pharma Corporation Information
    Table 85. Seoul Pharma Description and Business Overview
    Table 86. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 87. Seoul Pharma Erectile Dysfunction Product
    Table 88. Seoul Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 89. Seoul Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 90. Seoul Pharma Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 91. Yabang Pharmacy Corporation Information
    Table 92. Yabang Pharmacy Description and Business Overview
    Table 93. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 94. Yabang Pharmacy Erectile Dysfunction Product
    Table 95. Yabang Pharmacy Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Product in 2021
    Table 96. Yabang Pharmacy Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Sales Channels in 2021
    Table 97. Yabang Pharmacy Erectile Dysfunction Sales Proportion of Erectile Dysfunction by Geographic Area in 2021
    Table 98. Global Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 99. Global Erectile Dysfunction Sales Forecast by Type (2023-2028) & (Million Pill)
    Table 100. Global Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Global Erectile Dysfunction Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 102. Global Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 103. Global Erectile Dysfunction Sales Forecast by Sales Channels (2023-2028) & (Million Pill)
    Table 104. Global Erectile Dysfunction Revenue by Sales Channels (2017-2022) & (US$ Million)
    Table 105. Global Erectile Dysfunction Revenue Forecast by Sales Channels (2023-2028) & (US$ Million)
    Table 106. North America Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)
    Table 107. North America Erectile Dysfunction Sales by Country (2023-2028) & (Million Pill)
    Table 108. North America Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
    Table 109. North America Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
    Table 110. North America Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 111. North America Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 112. Asia-Pacific Erectile Dysfunction Sales by Region (2017-2022) & (Million Pill)
    Table 113. Asia-Pacific Erectile Dysfunction Sales by Region (2023-2028) & (Million Pill)
    Table 114. Asia-Pacific Erectile Dysfunction Revenue by Region (2017-2028) & (US$ Million)
    Table 115. Asia-Pacific Erectile Dysfunction Revenue by Region (2023-2028) & (US$ Million)
    Table 116. Asia-Pacific Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 117. Asia-Pacific Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 118. Europe Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)
    Table 119. Europe Erectile Dysfunction Sales by Country (2023-2028) & (Million Pill)
    Table 120. Europe Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
    Table 121. Europe Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
    Table 122. Europe Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 123. Europe Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 124. Latin America Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)
    Table 125. Latin America Erectile Dysfunction Sales by Country (2023-2028) & (Million Pill)
    Table 126. Latin America Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
    Table 127. Latin America Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
    Table 128. Latin America Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 129. Latin America Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 130. Middle East and Africa Erectile Dysfunction Sales by Country (2017-2022) & (Million Pill)
    Table 131. Middle East and Africa Erectile Dysfunction Sales by Country (2023-2028) & (Million Pill)
    Table 132. Middle East and Africa Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
    Table 133. Middle East and Africa Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
    Table 134. Middle East and Africa Erectile Dysfunction Sales by Type (2017-2022) & (Million Pill)
    Table 135. Middle East and Africa Erectile Dysfunction Sales by Sales Channels (2017-2022) & (Million Pill)
    Table 136. Erectile Dysfunction Key Raw Materials, Industry Status and Trend
    Table 137. Erectile Dysfunction Key Raw Materials and Upstream Suppliers
    Table 138. Erectile Dysfunction Clients Status and Trend
    Table 139. Erectile Dysfunction Typical Clients
    Table 140. Erectile Dysfunction Distributors
    Table 141. Erectile Dysfunction Market Trends
    Table 142. Erectile Dysfunction Market Drivers
    Table 143. Erectile Dysfunction Market Challenges
    Table 144. Erectile Dysfunction Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erectile Dysfunction Product Picture
    Figure 2. Global Erectile Dysfunction Sales Market Share by Type in 2021 & 2028
    Figure 3. Sildenafil Product Picture
    Figure 4. Tadalafil Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Erectile Dysfunction Sales Market Share by Sales Channels in 2021 & 2028
    Figure 7. Hospital Pharmacies Examples
    Figure 8. Private Clinics Examples
    Figure 9. Retail Pharmacies Examples
    Figure 10. E-Commerce (B2B) Examples
    Figure 11. E-Commerce (B2C) Examples
    Figure 12. Erectile Dysfunction Report Years Considered
    Figure 13. Global Erectile Dysfunction Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Erectile Dysfunction Market Size 2017-2028 (US$ Million)
    Figure 15. Global Erectile Dysfunction Sales 2017-2028 (Million Pill)
    Figure 16. Global Erectile Dysfunction Market Size Market Share by Region: 2022 Versus 2028
    Figure 17. Global Erectile Dysfunction Sales Market Share Forecast by Region (2017-2028)
    Figure 18. Global Erectile Dysfunction Revenue Market Share by Region (2017-2028)
    Figure 19. Global Erectile Dysfunction Sales Share by Manufacturer in 2021
    Figure 20. Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Erectile Dysfunction Sales Market Share Forecast by Type (2017-2028)
    Figure 22. Global Erectile Dysfunction Revenue Market Share Forecast by Type (2017-2028)
    Figure 23. Erectile Dysfunction Average Selling Price (ASP) by Type (2017-2022) & (USD/Pill)
    Figure 24. Global Erectile Dysfunction Sales Market Share Forecast by Sales Channels (2017-2028)
    Figure 25. Global Erectile Dysfunction Revenue Market Share Forecast by Sales Channels (2017-2028)
    Figure 26. Erectile Dysfunction Average Selling Price (ASP) by Sales Channels (2017-2022) & (USD/Pill)
    Figure 27. North America Erectile Dysfunction Revenue 2017-2028 (US$ Million)
    Figure 28. North America Erectile Dysfunction Sales Market Share by Type (2017-2022)
    Figure 29. North America Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)
    Figure 30. Asia-Pacific Erectile Dysfunction Revenue 2017-2028 (US$ Million)
    Figure 31. Asia-Pacific Erectile Dysfunction Sales Market Share by Region (2017-2028)
    Figure 32. Asia-Pacific Erectile Dysfunction Revenue Market Share by Region (2017-2028)
    Figure 33. Asia-Pacific Erectile Dysfunction Sales Market Share by Type (2017-2022)
    Figure 34. Asia-Pacific Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)
    Figure 35. Europe Erectile Dysfunction Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Europe Erectile Dysfunction Sales Market Share by Country (2017-2028)
    Figure 37. Europe Erectile Dysfunction Revenue Market Share by Country (2017-2028)
    Figure 38. Europe Erectile Dysfunction Sales Market Share by Type (2017-2022)
    Figure 39. Europe Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)
    Figure 40. Latin America Erectile Dysfunction Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 41. Latin America Erectile Dysfunction Sales Market Share by Country (2017-2028)
    Figure 42. Latin America Erectile Dysfunction Revenue Market Share by Country (2017-2022)
    Figure 43. Latin America Erectile Dysfunction Sales Market Share by Type (2017-2022)
    Figure 44. Latin America Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)
    Figure 45. Middle East and Africa Erectile Dysfunction Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 46. Middle East and Africa Erectile Dysfunction Sales Market Share by Country (2017-2028)
    Figure 47. Middle East and Africa Erectile Dysfunction Revenue Market Share by Country (2017-2028)
    Figure 48. Middle East and Africa Erectile Dysfunction Sales Market Share by Type (2017-2022)
    Figure 49. Middle East and Africa Erectile Dysfunction Sales Market Share by Sales Channels (2017-2022)
    Figure 50. Erectile Dysfunction Supply Chain (Upstream and Downstream Market)
    Figure 51. Global Production Market Share of Erectile Dysfunction Raw Materials by Region in 2021
    Figure 52. Erectile Dysfunction Distribution Channels
    Figure 53. Global Erectile Dysfunction Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 54. Global Erectile Dysfunction Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS